CVEvulnerability
CVE-2022-26239
5.5 MEDIUM
Official page ↗
- Status
- Modified
- Published
- 2022-10-06
- Last modified
- 2026-06-17
- Assigner
- [email protected]
- CVSS 3.1 ([email protected])
- 5.5 MEDIUM — CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N
- Weaknesses
- CWE-732
Description
The default privileges for the running service Normand License Manager in Beckman Coulter Remisol Advance v2.0.12.1 and prior allows unprivileged users to overwrite and manipulate executables and libraries. This allows attackers to access sensitive data.
Affected configurations
• beckmancoulter remisol advance (<= 2.0.12.1)
Related
Weakness · CWE (1)
- CWE-732 Incorrect Permission Assignment for Critical Resource weakness
References
- https://pastebin.com/1QEHrj01 Third Party Advisory
- https://www.beckmancoulter.com/products/clinical-information-management-tools/remisol-advance Product
- https://pastebin.com/1QEHrj01 Third Party Advisory
- https://www.beckmancoulter.com/products/clinical-information-management-tools/remisol-advance Product